A new publication involving plecanatide appeared on June 12, 2026. The article, titled "Irritable Bowel Syndrome with Constipation: Diagnosis and Multisymptom Management Beyond Abdominal Pain and Bowel Movement Frequency: A Review," was published in Advances in Therapy.
The review addresses diagnosis and multisymptom management of irritable bowel syndrome with constipation, looking beyond abdominal pain and bowel movement frequency alone. Plecanatide is referenced in this context as an approved therapy relevant to the condition discussed.
No specific findings, efficacy data, or safety outcomes from this review have been provided beyond its title and publication details. This brief reports only that the publication exists and where it appeared, without summarizing its conclusions or clinical implications.
Readers interested in plecanatide's approved indications and general background can consult the compound overview for further context.